INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Doctors discussing patient data-GettyImages-2214031965]( "Accelerating Recruitment In A Challenging Phase III Rare Disease Trial")
Accelerating Recruitment In A Challenging Phase III Rare Disease TrialRecruiting for rare acute diseases is challenging. Discover how this organization used rapid site activation and investigator engagement to speed enrollment in a Phase III Anti-GBM trial.
-
![Why Specialty Lab Samples Are So Vulnerable To Trial Execution Errors]( "Why Specialty Lab Samples Are So Vulnerable To Trial Execution Errors")
Why Specialty Lab Samples Are So Vulnerable To Trial Execution ErrorsBiomarkers and other specialty lab samples are among the most fragile parts of clinical trial execution, but what makes them so vulnerable to mishandling, and what are the effects?
-
![2020 Onsite Clinics]( "How State-Of-The-Art Clinical Trial Mobile Vision Clinics Work")
How State-Of-The-Art Clinical Trial Mobile Vision Clinics WorkAre you seeking a non-traditional option to complete the eye exams necessary for your ocular clinical trials? A mobile clinic may be the solution you're looking for.
-
![Checking prescription on smartphone-GettyImages-1719535353]( "Wearable Data Is Only Useful If It's There: Helping You Collect Your Study Data")
Wearable Data Is Only Useful If It's There: Helping You Collect Your Study DataNew, proactive alerts on this digital health platform ensure complete and high-quality data collection from wearable devices in clinical trials.
-
Why Inclusive Clinical Trials Win On Science, Speed, And Spend9/17/2025
Sponsors who proactively integrate diversity into their trial designs from the earliest phases are finding that it’s not only a matter of fairness but a strategic advantage.
-
Partnership Driving Superior Enrollment And Speed In Phase III Trial1/31/2025
Examine the partnership between CRIO and Sitero, including how it underscores the significant impact of technology in optimizing trial performance and accelerating treatment development.
-
Pharma R&D Annual Review Supplement: New Active Substances4/15/2026
Last year was by some distance the best year ever in terms of new active substances. Explore the 105 new debuts that easily outstrips that of the previous record holder, 2021’s, 97.
-
Why Clinical Trial Demographics Don't Match Real-World Populations12/4/2025
Representative trial demographics reduce bias, strengthen safety insights, and ensure therapies work for all. Learn why diversity is essential for accurate data and better health outcomes.
-
Real-World Data Has Real Impact On Clinical Research9/18/2025
The ultimate goal of using real-world data (RWD) in clinical research is to ensure a patient is on the right therapy and receiving the right care at the right point in their healthcare journey.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1819626829 patient recruitment]( "Precision Recruitment Is the Name of the Game")
Leverage an exhaustive view of patients, diseases, and providers to precisely identify protocol-specific populations within a sponsor’s site network.
-
![GettyImages-1358151834 ROI]( "Driving Efficiency And ROI In Clinical Trials")
Integrate sensors into your study to evaluate digital endpoints with a comprehensive solution that accelerates drug development, reduces patient sample sizes, cuts costs, and improves patient insights.
-
![iStock-187467661-quality-control-inspection]( "Navigating The Use Of Controlled Substances In Clinical Trials Using IRT")
Sponsor organizations that want to use controlled substances in clinical studies must manage the associated regulatory and logistical requirements. Read how this can be challenging for emerging biopharma.
-
![GettyImages-1489414892 Technological Software Engineering Department Manager Using A Laptop]( "Judi Core: Pre-Configured Solutions")
Eliminate manual friction and improve trial visibility with pre-configured, validated workflows. Standardize execution and ensure audit-ready data protection across every global site.
-
![GettyImages-1016958284 biosimilar lab]( "Every Decision Starts With The Right Biospecimen")
Learn how biospecimens, clinical data, cohort identification, and specialized laboratory services come together to support complex translational and biomarker research initiatives.
